KRTX - Karuna Therapeutics: Clear Path To NDA July, 15 2021 09:50 AM Karuna Therapeutics Inc. Combination therapy with patent protection through 2039. Sufficiently funded for cash run through 2023. Upcoming catalyst by the end of the year. For further details see: Karuna Therapeutics: Clear Path To NDA